• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Recent Advances in the Application of (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid (CAS: 182007-75-6) in Chemical Biology and Pharmaceutical Research

The compound (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid (CAS: 182007-75-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug synthesis and biological studies. This research brief aims to summarize the latest findings and advancements related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

Recent studies have highlighted the role of (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid as a key intermediate in the synthesis of chiral molecules, particularly in the development of protease inhibitors and other small-molecule therapeutics. Its unique structural features, including the tert-butoxy group and the chiral center, make it a valuable building block for asymmetric synthesis. Researchers have successfully employed this compound in the synthesis of novel antiviral and anticancer agents, demonstrating its broad utility in medicinal chemistry.

One of the most notable advancements involves the use of (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid in the development of targeted therapies for neurodegenerative diseases. Recent in vitro and in vivo studies have shown that derivatives of this compound exhibit promising neuroprotective effects, potentially through modulation of oxidative stress pathways. These findings open new avenues for the treatment of conditions such as Alzheimer's and Parkinson's diseases.

In addition to its therapeutic potential, (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid has also been investigated for its role in chemical biology. Researchers have utilized this compound as a probe to study enzyme mechanisms and protein-ligand interactions. Its ability to act as a substrate or inhibitor for specific enzymes has provided valuable insights into biochemical pathways and drug-target interactions.

The synthesis and scalability of (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid have also been areas of active research. Recent improvements in synthetic methodologies have enabled more efficient and cost-effective production of this compound, facilitating its broader application in both academic and industrial settings. These advancements are particularly important given the growing demand for chiral intermediates in pharmaceutical manufacturing.

Looking ahead, the potential applications of (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid continue to expand. Ongoing research is exploring its use in the development of next-generation antibiotics and immunomodulators, as well as its potential in personalized medicine. The compound's versatility and the recent breakthroughs in its application underscore its importance in advancing chemical biology and pharmaceutical research.

In conclusion, (S)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid (CAS: 182007-75-6) represents a valuable tool and intermediate in modern drug discovery and chemical biology. The latest research highlights its diverse applications, from therapeutic development to mechanistic studies, and underscores the need for continued investigation into its full potential. As synthetic methods improve and our understanding of its biological activities deepens, this compound is poised to play an increasingly significant role in addressing unmet medical needs.

• 90016-14-1(1,2,3-Propanetricarboxylic acid, 1-(1,1-dimethylethyl) 2,3-diethyl ester)
• 16537-12-5(Tert-butyl 2-methylbutanoate)
• 185836-75-3((R)-4-(Tert-Butoxy)-2-methyl-4-oxobutanoic acid)
• 200866-61-1((R)-(+)-2-Butylbutanedioic acid 4-tert-butyl ester)
• 1426307-23-4(Butanoic acid, 4-hydroxy-2-methyl-, 1,1-dimethylethyl ester, (2R)-)
• 121325-07-3((R)-3-(Tert-butoxycarbonyl)butanoic acid)
• 83253-51-4(4-Tert-butoxy-3-methyl-4-oxobutanoic acid)
• 71648-27-6(Hexanoic acid,2-ethyl-, 1,1-dimethylethyl ester)
• 112106-16-8((R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid)
• 132195-93-8(tert-butyl 2-methyl-4-oxobutanoate)